Stock 1752 NANG KUANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Nang Kuang Pharmaceutical Co., Ltd.

Equities

1752

TW0001752004

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
56.5 TWD +9.92% Intraday chart for Nang Kuang Pharmaceutical Co., Ltd. +24.45% +6.00%
May. 08 Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 26 Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Nang Kuang Pharmaceutical Co., Ltd. Announces Changes in Chief Internal Auditor
CI
Nang Kuang Pharmaceutical Co., Ltd. Appoints Pen-Sung Chen as Corporate Governance Officer
CI
Nang Kuang Pharmaceutical Co., Ltd. Announces Resignation of Wen-Yung Tsai as Spokesperson, Financial Officer, Accounting Officer and Corporate Governance Officer
CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Nang Kuang Pharmaceutical Co., Ltd.(TWSE:1752) added to S&P Global BMI Index
CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Nang Kuang Pharmaceutical Co., Ltd. Appoints Wen-Yung Tsai as Corporate Governance Officer
CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Nang Kuang Pharmaceutical : Announcement of the consolidated financial report for the 2nd quarter of 2022 approved by the board of directors
PU
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Nang Kuang Pharmaceutical : has received final U.S.FDA approval for its ANDA.
PU
Nang Kuang Pharmaceutical Co., Ltd. Receives Final U.S. FDA Approval for Its ANDA
CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Nang Kuang Pharmaceutical Co., Ltd.(TWSE:1752) added to Taiwan TAIEX Index
CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1752 Stock
  4. News Nang Kuang Pharmaceutical Co., Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW